Tapping the potential of fixed-dose combinations

Nature Reviews Drug Discovery

Volumn 6, Issue 7, 2007, Pages 513-514

  Herrick, Tara M ^a   Million, Ryan P ^a  

^a Trinity Partners   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; AMLODIPINE BESYLATE; AMLODIPINE PLUS ATORVASTATIN; AMLODIPINE PLUS VALSARTAN; ATORVASTATIN; ATORVASTATIN PLUS EZETIMIBE; BUDESONIDE PLUS FORMOTEROL; DUTASTERIDE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FAMOTIDINE; FAMOTIDINE PLUS IBUPROFEN; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FLUTIFORM; FORMOTEROL; HZT 501; IBUPROFEN; INDACATEROL; INDICATEROL PLUS MOMETASONE FUROATE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LORATADINE; LORATIDINE PLUS MONTELUKAST; MOMETASONE FUROATE; MONTELUKAST; NAPROXEN PLUS SUMATRIPTAN; SALMETEROL XINAFOATE; SIMVASTATIN; SUPER ADVAIR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG MARKETING; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG SYNTHESIS; HAY FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; MIGRAINE; PATENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY;

ASTHMA; DRUG COMBINATIONS; HIV INFECTIONS; HUMANS; HYPERLIPIDEMIAS;

EID: 34347394696     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2334     Document Type: Article

References (6)

1. Frantz, S. The trouble with making combination drugs. Nature Rev. Drug Discov. 5, 881-882 (2006).
2. National Institutes of Health. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute web site [online], (1997).
3. Nelson, H. S. et al. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J. Allergy Clin. Immunology 112, 29-36 (2003).
4. Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. AIDSinfo web site [online], (2006).
5. Berenson, A. Heart pill to be sold by itself. The New York Times (26 July 2006).
6. Schering-Plough. Press release: Schering-Plough and Merck to develop another new cholesterol lowering medicine. Schering-Plough web site [online] (26 March 2007).